Microsoft unveiled GigaTIME, an AI system trained on over 40 million cancer cells from more than 14,000 patients. The model can generate advanced immune cell imaging from standard tissue slides that cost roughly $10 each — a fraction of the price of specialized imaging techniques currently used in cancer research.
The system works by analyzing routine pathology slides and predicting what more expensive, high-resolution immune profiling would reveal. This means hospitals and research labs that cannot afford cutting-edge imaging equipment could still gain detailed insights into how a patient's immune system is responding to cancer.
Microsoft has released GigaTIME as an open-source tool, making it freely available to researchers worldwide. This move could significantly accelerate cancer immunology research, particularly in lower-resource settings where advanced imaging is not accessible.
For students studying AI in healthcare, GigaTIME is a clear example of how machine learning can make expensive medical processes cheaper and more widely available — one of the most promising applications of the technology.